医学
肝移植
肝细胞癌
背景(考古学)
肝病
结直肠癌
机器灌注
米兰标准
重症监护医学
肝切除术
肌萎缩
移植
胃肠病学
外科
内科学
癌症
切除术
古生物学
生物
作者
Norah A. Terrault,Claire Francoz,Marina Berenguer,Michael Charlton,Julie K. Heimbach
标识
DOI:10.1016/j.cgh.2023.04.005
摘要
Liver transplantation offers live-saving therapy for patients with complications of cirrhosis and stage T2 hepatocellular carcinoma. The demand for organs far outstrips the supply, and innovations aimed at increasing the number of usable deceased donors as well as alternative donor sources are a major focus. The etiologies of cirrhosis are shifting over time, with more need for transplantation among patients with alcohol-associated liver disease and nonalcoholic/metabolic fatty liver disease and less for viral hepatitis, although hepatitis B remains an important indication for transplant in countries with high endemicity. The rise in transplantation for alcohol-associated liver disease and nonalcoholic/metabolic fatty liver disease has brought attention to how patients are selected for transplantation and the strategies needed to prevent recurrent disease. In this review, we present a status report on the most pressing topics in liver transplantation and future challenges.
科研通智能强力驱动
Strongly Powered by AbleSci AI